Clariant (OTCMKTS:CLZNY) Downgraded by Zacks Research to “Strong Sell”

Zacks Research downgraded shares of Clariant (OTCMKTS:CLZNYFree Report) from a hold rating to a strong sell rating in a research report sent to investors on Wednesday morning,Zacks.com reports.

Separately, The Goldman Sachs Group cut shares of Clariant from a “buy” rating to a “sell” rating in a research note on Tuesday, February 10th. Two analysts have rated the stock with a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Reduce”.

Check Out Our Latest Research Report on Clariant

Clariant Price Performance

OTCMKTS:CLZNY opened at $9.76 on Wednesday. The firm’s 50-day moving average price is $10.30 and its 200-day moving average price is $9.72. Clariant has a 1-year low of $8.45 and a 1-year high of $12.82.

Clariant Company Profile

(Get Free Report)

Clariant AG is a Switzerland-based specialty chemicals company that traces its roots back to a spin-off from Sandoz in 1995. Headquartered in Muttenz near Basel, the firm develops, manufactures and markets a broad portfolio of chemical solutions for industries worldwide. While its primary listing is on the SIX Swiss Exchange, Clariant’s shares also trade OTC under the symbol CLZNY, reflecting its global investor reach.

The company operates through three core segments: Care Chemicals, Catalysis and Natural Resources.

Featured Stories

Receive News & Ratings for Clariant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clariant and related companies with MarketBeat.com's FREE daily email newsletter.